Q2 2020 Cytosorbents Corp Earnings Call Transcript
Good afternoon, and welcome to the CytoSorbents Second Quarter 2020 Financial and Operating Results Conference Call. (Operator Instructions) Please be advised that the call will be recorded at the company's request.
At this time, I'd like to turn the call over to our moderator, Jeremy Feffer. Please go ahead, sir.
Good afternoon, everyone. Welcome to CytoSorbents Second Quarter 2020 Financial and Operating Results Conference Call. Joining with me today are Dr. Phillip Chan, Chief Executive Officer; Vincent Capponi, Chief Operating Officer; Kathleen Bloch, Chief Financial Officer; Dr. Efthymios Deliargyris, Chief Medical Officer; Dr. Christian Steiner, Senior Vice President of Sales and Marketing from Germany; and Christopher Cramer, Vice President of Business Development.
Before I turn the call over to Dr. Chan, I'd like to remind listeners that management's prepared remarks may contain forward-looking statements, which are subject to risks. Management may make additional forward-looking statements to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |